Furthermore, AEA, an accepted agonist for CB1 and CB2, exerted anti-proliferative and pro-apoptotic effects on cholangiocarcinoma cells by activating GPR55 [23], although GPR55 is thought to promote tumor cell proliferation of other tumor entities [10,11,12]. The gene discussed is GPR55; the disease is cholangiocarcinoma.